ACV Auctions just reported its cleanest quarter yet — and the market responded by pushing the stock up 8% on the week before the earnings print even landed.
The Q1 numbers, released after the close on May 6, came in ahead of expectations on both lines. Revenue reached $204.2 million against a $201.7 million consensus, and the per-share loss of $0.06 was two cents better than the $0.08 estimate. Full-year guidance of $845–$855 million in sales landed broadly in line with forecasts. The headline that grabbed attention, though, was the $100 million buyback program — with management announcing intent to enter a $50 million accelerated repurchase immediately. For a stock trading near $5.40 after a near-29% wipeout in February, that signal landed loudly.
The positioning data tells a more measured story. Short interest has eased roughly 6% over the past month to around 5.9% of the free float — still meaningful, but directionally retreating. What's moved sharply the other way is the cost to borrow, which more than doubled in a week to 0.89%. That 105% weekly surge puts it at the highest level in the 30-day lookback window, even as absolute borrowing costs remain well below anything that would qualify as a squeeze setup. Availability in the lending market has tightened alongside the rising price — a natural byproduct of the stock's 24% rally over the past month drawing renewed short interest from those fading the move. Days to cover, per the latest FINRA read, stands at 4.3 days — not an extreme, but not dismissible either.
Options traders, meanwhile, are leaning constructively. The put/call ratio dropped to 0.43, slightly below its 20-day mean of 0.45 and nearly a full standard deviation to the bullish side. That's not a crowded call setup, but it reflects a market tilting toward participation over protection heading into the print. The 52-week range on the PCR runs from 0.02 to 0.55 — the current reading is well within the cautious-to-neutral zone, not yet signalling exuberance.
The Street has been slow to adjust after February's ugly reaction. Goldman Sachs maintained its Buy with a $10 target — cut from $13 — and Citigroup downgraded to Neutral in the wake of the Q4 miss, slashing its target from $13 to $7. Barclays has sat at Equal-Weight throughout, most recently at a $7 target. The consensus mean price target of around $8.98 implies roughly 66% upside to the current price, though the range of views is wide. Note that the most recent analyst data is from mid-April — any revisions following tonight's beat and the buyback announcement will be worth tracking in the coming days. The bull case rests on digital wholesale market share gains and the ACV Capital financing arm. Bears point to competition risk and sensitivity to used vehicle supply cycles.
Factor scores add texture to the setup. EPS surprise ranks in the 98th percentile — this is a company that consistently outpaces estimates. Thirty-day EPS momentum is similarly strong at the 91st percentile. The short score of 42.8 out of 100 sits in the lower half of the range, consistent with positioning that is cautious rather than aggressively bearish. The ORTEX short score has been creeping up over the past week — from 41.2 a week ago to 42.8 — suggesting shorts are not yet capitulating en masse despite the price recovery.
On the institutional side, Atreides Management entered the top holders with 12.4 million shares as of December, following an addition of 6.9 million shares in the period. Iridian Asset Management added 2.2 million shares and Frontier Capital added 1.6 million, both appearing recently in the top-15. These are active managers building size — not passive index flows. Against that, the cluster of April 1 insider sells by the CFO, COO, CEO and several C-suite members at $4.27 is notable in context — each was a small-dollar tax-withholding type transaction, and the stock has since rallied sharply, but the direction of insider flow on the open market has been consistently outward.
The next earnings date is May 27 — three weeks away — which means the market will be digesting tonight's beat, the buyback, and any analyst revisions throughout the month. Whether the borrow cost continues to climb as shorts reassess, or eases as positions are unwound, will be the cleaner signal to watch.
See the live data behind this article on ORTEX.
Open ACVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
